HOXA5 INHIBITS THE PROLIFERATION OF EXTRAHEPATIC CHOLANGIOCARCINOMA CELLS BY ENHANCING MXD1 EXPRESSION AND ACTIVATING THE P53 PATHWAY

HOXA5 inhibits the proliferation of extrahepatic cholangiocarcinoma cells by enhancing MXD1 expression and activating the p53 pathway

Abstract Homeobox A5 (HOXA5) is a transcription factor in mammalian and can regulate cell differentiation, proliferation, and apoptosis as well as tumorigenesis.However, little is known on whether and how HOXA5 can regulate the malignant behaviors of cholangiocarcinoma.The methylation levels of HOXA5 were evaluated by methylation microarray and bis

read more


COMBINATION THERAPY IN THE MANAGEMENT OF ARTERIAL HYPERTENSION: EFFECTIVENESS OF THE LERCANIDIPINE AND ENALAPRIL COMBINATION

This review presents the evidence on the benefits of fixed-dose combination therapy for arterial hypertension management.The focus is on the combination of a third-generation dihydropyridine calcium antagonist lercanidipine and an ACE inhibitor enalapril.Lercanidipine is characterised by high vascular selectivity and 4 pin DIN Cable lipophilicity,

read more